Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban

References

• Papatsonis D, Flenady V, Cole S, et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev. 2005;(3):CD004452.
   PubMedGoogle Scholar
• Lamont RF, Kam KR. Atosiban as a tocolytic for the treatment of spontaneous preterm labor. Expert Rev Obstet Gynecol. 2008;3(2):163–174.
   Google Scholar
• Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 2000;182(5):1173–1183.
   PubMed Web of Science ®Google Scholar
• Flenady V, Reinebrant HE, Liley HG, et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;1:22–42.
   Web of Science ®Google Scholar
• Lamont CD, Jørgensen JS, Lamont RF. The safety of tocolytics used for the inhibition of preterm labour. Expert Opin Drug Saf. 2016;15(9):1163–1173.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Phase III efficacy and safety study of intravenous retosiban versus placebo for women in spontaneous preterm labor (NEWBORN-1; March 2015; [cited 2020 Nov 21]. Available from: https://clinicaltrials.gov/ct2/show/NCT02377466.
   Google Scholar
• Eunice Kennedy Shriver National Institute of Child Health. Human Development. National Institutes of Health (NIH), Department of Health and Human Services (DHHS). Preterm labor and birth: condition information. 2014.
   Google Scholar
• American College of Obstetricians and Gynecologists. Practice bulletin No. 171: management of preterm labor. Obstet Gynecol. 2016;128:155–164.
   PubMedGoogle Scholar
• Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371(9608):261–269.
   PubMed Web of Science ®Google Scholar
• Petrini JR, Dias T, McCormick MC, et al. Increased risk of adverse neurological development for late preterm infants. J Pediatr. 2009;154(2):169–176.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Friedman AM, Gyamfi-Bannerman C. Epidemiology of moderate preterm, late preterm and early term delivery. Clin Perinatol. 2013;40(4):601–610.
   PubMed Web of Science ®Google Scholar
• Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345(6198):760–765.
   PubMed Web of Science ®Google Scholar
• Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88(1):31–38.
   PubMed Web of Science ®Google Scholar
• Dolan SM, Gross SJ, Merkatz IR, et al. The contribution of birth defects to preterm birth and low birth weight. Obstet Gynecol. 2007;110(2 Pt 1):318–324.
   PubMed Web of Science ®Google Scholar
• Been JV, Nurmatov UB, Cox B, et al. Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet. 2014;383(9928):1549–1560.
   PubMed Web of Science ®Google Scholar
• Smith GCS, Pell JP, Dobbie R. Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study. BMJ. 2003;327(7410):310–313.
   PubMedGoogle Scholar
• Braveman P, Heck K, Egerter S, et al. Worry about racial discrimination: a missing piece of the puzzle of Black-White disparities in preterm birth? PLoS One. 2017;12(10):e0186151.
   PubMed Web of Science ®Google Scholar
• Korten I, Ramsey K, Latzin P. Air pollution during pregnancy and lung development in the child. Paediatr Respir Rev. 2017;21:38–46.
   PubMed Web of Science ®Google Scholar
• Malley CS, Kuylenstierna JC, Vallack HW, et al. Preterm birth associated with maternal fine particulate matter exposure: a global, regional and national assessment. Environ Int. 2017;101:173–182.
   PubMed Web of Science ®Google Scholar
• Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61(3):418–426.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams JD, Mercer BM, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU NetworkAm J Public Health. 1998;88(2):233–238.
   PubMed Web of Science ®Google Scholar
• Suman V, Luther EE. Preterm labor. updated 2020. StatPearls; [cited 2021 Mar 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK5369392020.
   Google Scholar
• Bassan H. Intracranial hemorrhage in the preterm infant: understanding it, preventing it. Clin Perinatol. 2009;36(4):737–762.
   PubMed Web of Science ®Google Scholar
• Hafström M, Källén K, Serenius F, et al. Cerebral palsy in extremely preterm infants. Pediatrics. 2018;141(1):e20171433.
   PubMed Web of Science ®Google Scholar
• Chalak LF, Rollins N, Morriss MC, et al. Perinatal acidosis and hypoxic-ischemic encephalopathy in preterm infants of 33 to 35 weeks’ gestation. J Pediatr. 2012;160(3):388–394.
   PubMed Web of Science ®Google Scholar
• Hellström A, Smith LEH, Dammann O. Retinopathy of prematurity. Lancet. 1991;337:83–84.
   PubMed Web of Science ®Google Scholar
• Zhao J, Gonzalez F, Mu D. Apnea of prematurity: from cause to treatment. Eur J Pediatr. 2011;170(9):1097–1105.
   PubMed Web of Science ®Google Scholar
• Benitz WE. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137(1):e20153730.
   Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Respiratory distress syndrome; [cited 2021 Jun 18]. Available from: https://www.nhlbi.nih.gov/health-topics/respiratory-distress-syndrome.
   Google Scholar
• Choudhuri P, Chaudhuri D, Bhattacharya N. Problems of extreme prematurity. Human fetal growth and development. Cham (CH): Springer; 2016. 561–569.
   Google Scholar
• Malik A, Amin G, Alvi HT, et al. Hematological profile of preterm infants suffering from anemia. Int J Biol Pharm Allied Sci. 2018;7:159–165.
   Google Scholar
• Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med. 2007;357(5):477–487.
   PubMed Web of Science ®Google Scholar
• Haas DM, Caldwell DM, Kirkpatrick P, et al. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012;345:e6226.
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Malamas FM, Sifakis S, et al. The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents. Int J Endocrinol. 2011;2011:350546.
   PubMed Web of Science ®Google Scholar
• Shmygol A, Gullam J, Blanks A, et al. Multiple mechanisms involved in oxytocin-induced modulation of myometrial contractility. Acta Pharmacol Sin. 2006;27(7):827–832.
   PubMed Web of Science ®Google Scholar
• Papatsonis D, Flenady V, Liley H. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2009;(1):CD005938.
   Google Scholar
• Al-Omari WR, Al-Shammaa HB, Al-Tikriti EM, et al. Atosiban and nifedipine in acute tocolysis: a comparative study. Eur J Obstet Gynecol Reprod Biol. 2006;128(1–2):129–134.
   PubMed Web of Science ®Google Scholar
• Kashanian M, Akbarian AR, Soltanzadeh M. Atosiban and nifedipin for the treatment of preterm labor. Int J Gynaecol Obstet. 2005;91(1):10–14.
   PubMed Web of Science ®Google Scholar
• Nisell H, Wolff K. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG. 2003;108:133–142.
   Google Scholar
• Goodwin TM, Valenzuela GJ, Silver H, et al. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Obstet Gynecol. 1996;88(3):331–336.
   PubMed Web of Science ®Google Scholar
• Bittar RE, Zugaib M. Tratamento do trabalho de parto premature [Treatment of premature labor]. Rev Bras Ginecol e Obstet. 2009;31:415–422. Portuguese.
   Google Scholar
• Moutquin JM, Sherman D, Cohen H, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol. 2000;182(5):1191–1199.
   PubMed Web of Science ®Google Scholar
• Manning M, Stoev S, Chini B, et al. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res. 2008;170:473–512.
   PubMed Web of Science ®Google Scholar
• Cuppett CD, Caritis SN. Uterine contraction agents and tocolytics. Clinical pharmacology during pregnancy. London (UK): Elsevier; 2013. 307–330.
   Google Scholar
• Waller DG, Sampson AP. Female reproduction. Medical pharmacology and therapeutics. London (UK): Elsevier; 2018. 513–529.
   Google Scholar
• Maggioni AP, Franzosi MG, Latini R. Beta-adrenoceptor antagonists and antianginal drugs. Side effects of drugs annual. London (UK): Elsevier; 2008. 223–230.
   Google Scholar
• Liddle J, Allen MJ, Borthwick AD, et al. The discovery of GSK221149A: a potent and selective oxytocin antagonist. Bioorg Med Chem Lett. 2008;18(1):90–94.
   PubMed Web of Science ®Google Scholar
• Borthwick AD, Liddle J. The design of orally bioavailable 2, 5-diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labor. Med Res Rev. 2011;31(4):576–604.
   PubMed Web of Science ®Google Scholar
• McCafferty GP, Pullen MA, Wu C, et al. Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat. Am J Physiol Regul Integr Comp Physiol. 2007;293:299–305.
   Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103–112.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Cochrane book series. Chichester (UK): Wiley; 2008. p. 1–649.
   Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.
   PubMed Web of Science ®Google Scholar
• Thornton S, Miller H, Valenzuela G, et al. Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study. Br J Clin Pharmacol. 2015;80(4):740–749.
   PubMed Web of Science ®Google Scholar
• Thornton S, Valenzuela G, Baidoo C, et al. Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging study. Br J Clin Pharmacol. 2017;83(10):2283–2291.
   PubMed Web of Science ®Google Scholar